Pay in 4 interest-free payments of $5.92 Learn more
![tirzepatide surpass trials Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Efficacy and safety of a](https://www.researchgate.net/publication/363201315/figure/fig3/AS:11431281082605778@1662084799021/Efficacy-of-tirzepatide-in-phase-2-GPGB-14-and-phase-3-SURPASS-1-to-5-15-19.png)
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Osho notes
![tirzepatide surpass trials Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Efficacy and safety of a](https://www.thelancet.com/cms/asset/96874444-5a73-45b6-bf8b-16e5835720ab/gr2.jpg)
Weight loss injections are recommended for those with a BMI of 30 or higher or a BMI of 27 or higher with a weight-related condition
![tirzepatide surpass trials Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Efficacy and safety of a](https://digimedupdates.com/wp-content/uploads/2025/10/Screenshot-2025-10-02-195233.png)
J Biol Chem 267(11):74027405 Schirra J, Sturm K, Leicht P, Arnold R, Goke B, Katschinski M (1998) Exendin(939)amide is an antagonist of glucagon-like peptide-1(736)amide in humans
![tirzepatide surpass trials Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Efficacy and safety of a](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13300-024-01620-8/MediaObjects/13300_2024_1620_Fig3_HTML.png)
Dehydration GLP-1 medications can cause gastrointestinal side effects including nausea, vomiting, and diarrhea, especially in the early weeks
![tirzepatide surpass trials Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Efficacy and safety of a](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-024-02147-9/MediaObjects/12933_2024_2147_Fig1_HTML.png)
US$ 29.96
US$ 29.09
US$ 29.95
US$ 28.13
